These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 9559887)
1. Elevated plasma endothelin-1 level in streptozotocin-induced diabetic rats and responsiveness of the mesenteric arterial bed to endothelin-1. Makino A; Kamata K Br J Pharmacol; 1998 Mar; 123(6):1065-72. PubMed ID: 9559887 [TBL] [Abstract][Full Text] [Related]
2. Time-course changes in plasma endothelin-1 and its effects on the mesenteric arterial bed in streptozotocin-induced diabetic rats. Makino A; Kamata K Diabetes Obes Metab; 2000 Jan; 2(1):47-55. PubMed ID: 11220354 [TBL] [Abstract][Full Text] [Related]
3. Possible modulation by endothelin-1, nitric oxide, prostaglandin I2 and thromboxane A2 of vasoconstriction induced by an alpha-agonist in mesenteric arterial bed from diabetic rats. Makino A; Kamata K Diabetologia; 1998 Dec; 41(12):1410-8. PubMed ID: 9867207 [TBL] [Abstract][Full Text] [Related]
4. Effects of chronic administration of L-arginine on vasoactive responses induced by endothelin-1 and its plasma level in streptozotocin-induced diabetic rats. Makino A; Kamata K J Smooth Muscle Res; 2002 Oct; 38(4-5):101-15. PubMed ID: 12596889 [TBL] [Abstract][Full Text] [Related]
5. Discrimination between ETA- and ETB-receptor-mediated effects of endothelin-1 and [Ala1,3,11,15]endothelin-1 by BQ-123 in the anaesthetized rat. Bigaud M; Pelton JT Br J Pharmacol; 1992 Dec; 107(4):912-8. PubMed ID: 1467841 [TBL] [Abstract][Full Text] [Related]
6. Involvement of NO and MEK/ERK pathway in enhancement of endothelin-1-induced mesenteric artery contraction in later-stage type 2 diabetic Goto-Kakizaki rat. Matsumoto T; Ishida K; Nakayama N; Kobayashi T; Kamata K Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1388-97. PubMed ID: 19286964 [TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor tyrosine kinase-mediated signalling contributes to diabetes-induced vascular dysfunction in the mesenteric bed. Benter IF; Yousif MH; Griffiths SM; Benboubetra M; Akhtar S Br J Pharmacol; 2005 Jul; 145(6):829-36. PubMed ID: 15852031 [TBL] [Abstract][Full Text] [Related]
8. Attenuated agonist evoked vasoconstrictor responses in the perfused mesenteric vascular bed of streptozotocin diabetic rats. Misurski DA; Hopfner RL; Gopalakrishnan V Exp Biol Med (Maywood); 2001 Nov; 226(10):940-6. PubMed ID: 11682701 [TBL] [Abstract][Full Text] [Related]
9. Role of 20-hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes. Yousif MH; Benter IF; Dunn KM; Dahly-Vernon AJ; Akhtar S; Roman RJ Auton Autacoid Pharmacol; 2009 Jan; 29(1-2):1-12. PubMed ID: 19302551 [TBL] [Abstract][Full Text] [Related]
10. Pharmacology of endothelins in vascular circuits of normal or heterozygous endothelin-A or endothelin-B knockout transgenic mice. Berthiaume N; Yanagisawa M; Yanagisawa H; deWit D; D'Orléans-Juste P J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S561-4. PubMed ID: 9595543 [TBL] [Abstract][Full Text] [Related]
11. The vasoconstriction induced by endothelin-1 is mediated only by ET(A) receptors in mesenteric small resistance arteries of spontaneously hypertensive rats and Wistar Kyoto rats. Rizzoni D; Porteri E; Piccoli A; Castellano M; Bettoni G; Pasini G; Agabiti-Rosei E J Hypertens; 1997 Dec; 15(12 Pt 2):1653-7. PubMed ID: 9488218 [TBL] [Abstract][Full Text] [Related]
12. Impaired sensory-motor nerve function in the isolated mesenteric arterial bed of streptozotocin-diabetic and ganglioside-treated streptozotocin-diabetic rats. Ralevic V; Belai A; Burnstock G Br J Pharmacol; 1993 Nov; 110(3):1105-11. PubMed ID: 8298799 [TBL] [Abstract][Full Text] [Related]
13. Activation of endothelin ETA receptors masks the constrictor role of endothelin ETB receptors in rat isolated small mesenteric arteries. Mickley EJ; Gray GA; Webb DJ Br J Pharmacol; 1997 Apr; 120(7):1376-82. PubMed ID: 9105715 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the contractile and calcium-increasing properties of platelet-activating factor and endothelin-1 in the rat mesenteric artery and vein. Claing A; Shbaklo H; Plante M; Bkaily G; D'Orléans-Juste P Br J Pharmacol; 2002 Jan; 135(2):433-43. PubMed ID: 11815379 [TBL] [Abstract][Full Text] [Related]
16. Enhanced response of pig coronary arteries to endothelin-1 after ischemia-reperfusion. Role of endothelin receptors, nitric oxide and prostanoids. Climent B; Fernández N; Sanz E; Sánchez A; Monge L; García-Villalón AL; Diéguez G Eur J Pharmacol; 2005 Nov; 524(1-3):102-10. PubMed ID: 16243311 [TBL] [Abstract][Full Text] [Related]
17. Endothelium-dependent mesenteric vasorelaxant effects and systemic actions of endothelin (16-21) and other endothelin-related peptides in the rat. Douglas SA; Hiley CR Br J Pharmacol; 1991 Oct; 104(2):311-20. PubMed ID: 1797300 [TBL] [Abstract][Full Text] [Related]
18. Use of A-192621 and IRL-2500 to unmask the mesenteric and renal vasodilator role of endothelin ET(B) receptors. Leung SW; Lim SL; Pang CC; Man RY J Cardiovasc Pharmacol; 2002 Apr; 39(4):533-43. PubMed ID: 11904527 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms underlying enhanced contractile response to endothelin-1 in diabetic rat basilar artery. Matsumoto T; Yoshiyama S; Kobayashi T; Kamata K Peptides; 2004 Nov; 25(11):1985-94. PubMed ID: 15501531 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms underlying the attenuation of endothelium-dependent vasodilatation in the mesenteric arterial bed of the streptozotocin-induced diabetic rat. Makino A; Ohuchi K; Kamata K Br J Pharmacol; 2000 Jun; 130(3):549-56. PubMed ID: 10821782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]